Internal Medicine, Endocrinology, Diabetes, & Metabolism · Berkley, MI
NPI
1285715409
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1949 West Twelve Mile Road, Ste 200
Berkley, MI, 48072
Phone (248) 543-3700
Groups this clinician bills Medicare through
Medicare paid, 2024
$135K
2,237 services
Medicare patients, 2024
574
Average age 74
Drug cost, 2024
$1.5M
2,963 prescriptions
Company payments, 2025
$3,338
From 30 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alla A Sakharova was code 99214 (office e&m - established), 642 times for 361 patients. In total Alla A Sakharova billed 2,237 services in 23 codes, and Medicare paid $135K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 642 | 361 | $82.99 | $53K |
| 95251 Test - Miscellaneous | Office | 280 | 119 | $23.71 | $6,638 |
| 99215 Office E&M - Established | Office | 264 | 258 | $111.39 | $29K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 260 | 155 | $11.10 | $2,885 |
| 99231 Hospital E&M - Subsequent | Facility | 254 | 61 | $35.93 | $9,125 |
| 99232 Hospital E&M - Subsequent | Facility | 143 | 62 | $56.04 | $8,014 |
| 96127 Behavioral Health Services | Office | 66 | 65 | $3.29 | $217 |
| 99205 Office E&M - New | Office | 66 | 66 | $148.28 | $9,787 |
| 82962 Clinical Chemistry | Office | 58 | 51 | $3.21 | $186 |
| 99223 Hospital E&M - Initial | Facility | 45 | 41 | $125.92 | $5,666 |
| 60100 Other Organ Systems | Office | 35 | 26 | $39.85 | $1,395 |
| 10005 Other Organ Systems | Office | 26 | 26 | $81.93 | $2,130 |
| 95250 Test - Miscellaneous | Office | 17 | 17 | $98.05 | $1,667 |
| 99457 E&M - Miscellaneous | Office | 16 | 16 | $32.98 | $528 |
| 99443 Telephone Services | Office | 15 | 14 | $93.26 | $1,399 |
By year: 2022 $215K for 5,751 services; 2023 $168K for 2,429 services; 2024 $135K for 2,237 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 58 | 51 | $3.21 | $186 |
Medicare prescription drug claims, 2024
In 2024, the drug Alla A Sakharova prescribed most often to Medicare patients was Ozempic (Semaglutide), with 273 prescriptions and refills. In total Alla A Sakharova wrote 2,963 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 273 | 400 | 82 | $374K |
| Levothyroxine Sodium Generic | 256 | 726 | 110 | $3,245 |
| Repaglinide Generic | 172 | 469 | 71 | $14K |
| Synthroid Levothyroxine Sodium | 169 | 456 | 65 | $19K |
| Mounjaro Tirzepatide | 166 | 206 | 46 | $210K |
| Metformin Hcl Generic | 126 | 363 | 70 | $1,607 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 117 | 307 | 61 | $22K |
| Jardiance Empagliflozin | 109 | 282 | 56 | $161K |
| Tradjenta Linagliptin | 81 | 129 | 24 | $63K |
| Trulicity Dulaglutide | 60 | 103 | 26 | $95K |
| Pioglitazone Hcl Generic | 58 | 152 | 24 | $980 |
| Atorvastatin Calcium Generic | 53 | 151 | 25 | $611 |
| Metformin Hcl Er Metformin Hcl | 52 | 134 | 27 | $739 |
| Farxiga Dapagliflozin Propanediol | 51 | 106 | 19 | $58K |
| Gabapentin Generic | 48 | 129 | 25 | $1,495 |
Brand drugs: 1,590 claims; generic drugs: 1,202 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alla A Sakharova $3,338 ($3,338 in general payments such as food, travel and fees) from 30 companies. The largest payer was Novo Nordisk Inc with $355.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 17 | $355 |
| Mannkind Corporation MNKD | 20 | $344 |
| Amgen Inc. AMGN | 17 | $334 |
| Neurocrine BioSciences, Inc. NBIX | 6 | $261 |
| Xeris Pharmaceuticals, Inc. | 12 | $207 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $198 |
| Ascendis Pharma Endocrinology Inc ASND | 6 | $193 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 8 | $141 |
| Lilly USA, LLC LLY | 9 | $131 |
| Dexcom, Inc. DXCM | 6 | $117 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.